A Novel Bioabsorbable Sheet That Delivers NF-κB Decoy Oligonucleotide Restrains Abdominal Aortic Aneurysm Development in Rats-Reference-Cited by-同舟云学术

A Novel Bioabsorbable Sheet That Delivers NF-κB Decoy Oligonucleotide Restrains Abdominal Aortic Aneurysm Development in Rats

Published:2018-09-01 Issue:5 Volume:59 Page:1134-1141
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Akimoto Shouta¹,Suzuki Jun-ichi¹,Aoyama Norio²,Ikeuchi Ryota³,Watanabe Hajime³,Tsujimoto Hiroyuki⁴,Wakayama Kouji¹,Kumagai Hidetoshi¹,Ikeda Yuichi⁵,Akazawa Hiroshi⁵,Komuro Issei⁵

Affiliation:

1. Department of Advanced Clinical Science and Therapeutics, School of Medicine, The University of Tokyo

2. Department of Oral Interdisciplinary Medicine, Kanagawa Dental University

3. AnGes, Inc.

4. Hosokawa Micron Co.

5. Department of Cardiovascular Medicine, School of Medicine, The University of Tokyo

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/59/5/59_17-632/_pdf

Reference22 articles.

1. 1. Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet 2005; 365: 1577-89.

2. 2. Miyake T, Morishita R. Pharmacological treatment of abdominal aortic aneurysm. Cardiovasc Res 2009; 83: 436-43.

3. 3. Zhang R, Chen S, Zhang H, et al. Biomarkers investigation for in-hospital death in patients with Stanford type A acute aortic dissection. Int Heart J 2016; 57: 622-6.

4. 4. Treska V, Kocova J, Boudova L, et al. Inflammation in the wall of abdominal aortic aneurysm and its role in the symptomatology of aneurysm. Cytokines Cell Mol Ther 2002; 7: 91-7.

5. 5. Daugherty A, Cassis LA. Mechanisms of abdominal aortic aneurysm formation. Curr Atheroscler Rep 2002; 4: 222-7.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-siRNA nanoparticles targeting NF-κB p50 mitigate experimental abdominal aortic aneurysm progression and rupture;Biomaterials Advances;2022-08

2. Research and development of oligonucleotide therapeutics in Japan for rare diseases;Future Rare Diseases;2022-03

3. Harnessing the Therapeutic Potential of Decoys in Non-Atherosclerotic Cardiovascular Diseases: State of the Art;Journal of Cardiovascular Development and Disease;2021-08-27

4. Unique Mechanism by Which TGFBR1 Variants Cause 2 Distinct System Diseases　― Loeys-Dietz Syndrome and Multiple Self-Healing Squamous Epithelioma ―;Circulation Reports;2019-11-08